SCHEMBL29474946

SCHEMBL29474946

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ NPY1R P25929 2/20 0.61
▸ NPY2R P49146 2/20 0.61
▸ NPY4R P50391 2/20 0.61
▸ NTSR1 P30989 8/20 0.59
▸ NTSR2 O95665 4/20 0.59
▸ SORT1 Q99523 1/20 0.55
▸ KISS1R Q969F8 2/20 0.55
▸ BACE1 P56817 2/20 0.54
▸ NPY5R Q15761 1/20 0.52
▸ BACE2 Q9Y5Z0 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29819595 0.93 NPY1R (0.69) NPY1RNPY2RNPY4RNTSR1NTSR2
SCHEMBL29659439 0.91 NPY1R (0.67) NPY1RNPY2RNPY4RNTSR1NTSR2
SCHEMBL29500254 0.87 NPY1R (0.63) NPY1RNPY2RNPY4RNTSR1NTSR2
SCHEMBL29361975 0.86 EGFR (0.60) NPY1RNPY2RNPY4RNTSR1NTSR2
Fluoro[Hydroxy(Phenyl)Phosphoryl]Methyl(Phenyl)Phosphinic Acid SCHEMBL29387961 0.86 EGFR (0.65) NPY1RNPY2RNPY4RNTSR1NTSR2
Fluoro[Hydroxy(Phenyl)Phosphoryl]Methyl(Phenyl)Phosphinic Acid SCHEMBL31414724 0.86 EGFR (0.65) NPY1RNPY2RNPY4RNTSR1NTSR2
SCHEMBL29572333 0.86 BACE1 (0.62) KISS1RBACE1BACE2
SCHEMBL31756855 0.86 NTSR1 (0.66) NPY1RNPY2RNPY4RNTSR1NTSR2
SCHEMBL30513621 0.84 BACE1 (0.66) BACE1BACE2
SCHEMBL31536321 0.83 BACE1 (0.72) BACE1BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4649954-A2 METHOD FOR MANUFACTURING A STABLE EMULSION FOR PEPTIDE DELIVERY OSE IMMUNOTHERAPEUTICS (FR) 2025-11-19 — — EP disclosed
EP-4029494-B1 METHOD FOR MANUFACTURING A STABLE EMULSION FOR PEPTIDE DELIVERY OSE IMMUNOTHERAPEUTICS (FR) 2025-09-24 — — EP disclosed
US-11981713-B2 Method for manufacturing a stable emulsion for peptide delivery OSE IMMUNOTHERAPEUTICS (FR) 2024-05-14 — — US disclosed
CN-114917189-A Method of making stable emulsions for peptide delivery 奥塞免疫疗法公司 2022-08-19 — — CN disclosed
US-20220259277-A1 METHOD FOR MANUFACTURING A STABLE EMULSION FOR PEPTIDE DELIVERY OSE IMMUNOTHERAPEUTICS (FR) 2022-08-18 — — US disclosed
EP-4029494-A1 METHOD FOR MANUFACTURING A STABLE EMULSION FOR PEPTIDE DELIVERY OSE Immunotherapeutics (FR) 2022-07-20 — — EP disclosed
US-11325959-B2 Method for manufacturing a stable emulsion for peptide delivery OSE IMMUNOTHERAPEUTICS (FR) 2022-05-10 — — US disclosed
CN-110191703-B Method of making stable emulsions for peptide delivery 奥塞免疫疗法公司 2022-04-08 — — CN disclosed
EP-3573600-B1 METHOD FOR MANUFACTURING A STABLE EMULSION FOR PEPTIDE DELIVERY OSE IMMUNOTHERAPEUTICS (FR) 2022-03-02 — — EP disclosed
Send feedback